Anti-CTDSP1 / SCP1 Antibody (C-Terminus)
| Name | Anti-CTDSP1 / SCP1 Antibody (C-Terminus) |
|---|---|
| Supplier | LifeSpan Bioscience |
| Catalog | LS-C101056 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Applications | IHC-P WB |
| Species Reactivities | Human |
| Antigen | CTDSP1 / SCP1 antibody was raised against kLH conjugated synthetic peptide selected from the C-terminal region of human CTDSP1-V250 protein |
| Blocking Peptide | CTDP1 / FCP1 Antibody Blocking Peptide |
| Description | Rabbit Polyclonal |
| Gene | CTDSP1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.
The anti-CTDSP1-V250 is used in Western blot to detect CTDSP1-V250 in CEM tissue lysate.
Western blot of CTDSP1 (arrow) using CTDSP1-V250 Antibody. 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the CTDSP1 gene (Lane 2) (Origene Technologies).